Squamous lung cancer treatment: what to know

A biopsy identifies the cancer type, while scans show where it is and whether it can be treated locally. Genomic tumour profiling may look for changes that affect medicine choices. The team also considers breathing function, other illnesses, previous treatments and what matters most to you. Early or localised disease may be approached with surgery, radiotherapy or both. More extensive disease often needs treatment that travels through the bloodstream, sometimes combined with focused radiotherapy. A treatment plan can change when scans, symptoms or side effects change.

Ask for the purpose and schedule of every treatment, along with the symptoms to report. Before chemotherapy or immunotherapy, tell the team about medicines, supplements, infections and autoimmune conditions. If surgery is proposed, discuss lung function testing, recovery and whether a lung lobectomy or another operation is appropriate. Radiotherapy planning maps the target while protecting nearby tissue. Palliative care can help with pain, cough, appetite, fatigue, sleep and coping at any stage. Keep a written list of appointments and side effects so your team can adjust support early.

Call your treatment team promptly for fever, worsening cough, new breathlessness, chest pain, repeated vomiting, diarrhoea, unusual bleeding or a rapidly worsening rash. Emergency assessment is needed for severe breathing difficulty, fainting, severe allergic symptoms, new confusion or sudden weakness. Do not wait for the next appointment if a side effect is intense or arrives quickly.

What is the stage and treatment goal? Is genomic tumour profiling useful for me? Why is this treatment preferred over another? How will you check whether it is working? Which side effects need an urgent call? Who should I contact outside clinic hours?